Published in Endocrinology on March 01, 1991
Development of the osteoblast phenotype: molecular mechanisms mediating osteoblast growth and differentiation. Iowa Orthop J (1995) 1.60
Bone disease in multiple myeloma: pathophysiology and management. Cancer Growth Metastasis (2014) 1.22
Dietary induced subclinical vitamin K deficiency in normal human subjects. J Clin Invest (1993) 1.12
Regulation of angiogenesis during osseointegration by titanium surface microstructure and energy. Biomaterials (2010) 1.11
Vitamin D and bone. Curr Osteoporos Rep (2012) 1.08
Effects of 25-hydroxyvitamin D(3) on proliferation and osteoblast differentiation of human marrow stromal cells require CYP27B1/1α-hydroxylase. J Bone Miner Res (2011) 1.05
In vitro and in vivo evidence for orphan nuclear receptor RORalpha function in bone metabolism. Proc Natl Acad Sci U S A (2000) 1.05
A potential role for tetranectin in mineralization during osteogenesis. J Cell Biol (1994) 1.01
Regulation of the gp80 and gp130 subunits of the IL-6 receptor by sex steroids in the murine bone marrow. J Clin Invest (1997) 0.97
Vitamin D receptor ChIP-seq in primary CD4+ cells: relationship to serum 25-hydroxyvitamin D levels and autoimmune disease. BMC Med (2013) 0.97
Calcium nutrition and extracellular calcium sensing: relevance for the pathogenesis of osteoporosis, cancer and cardiovascular diseases. Nutrients (2013) 0.94
Osteoblast-specific transcription factor Osterix increases vitamin D receptor gene expression in osteoblasts. PLoS One (2011) 0.94
Evidence for a calcification process in the trabecular meshwork. Exp Eye Res (2008) 0.91
Postproliferative transcription of the rat osteocalcin gene is reflected by vitamin D-responsive developmental modifications in protein-DNA interactions at basal and enhancer promoter elements. Proc Natl Acad Sci U S A (1993) 0.91
Vitamin D and gene networks in human osteoblasts. Front Physiol (2014) 0.89
Vitamin D-responsive protein-DNA interactions at multiple promoter regulatory elements that contribute to the level of rat osteocalcin gene expression. Proc Natl Acad Sci U S A (1992) 0.88
Expression of the gene encoding the matrix gla protein by mature osteoblasts in human fracture non-unions. Mol Pathol (1999) 0.86
The role of the gastrointestinal tract in calcium homeostasis and bone remodeling. Osteoporos Int (2013) 0.85
Constitutive transcription of the osteocalcin gene in osteosarcoma cells is reflected by altered protein-DNA interactions at promoter regulatory elements. Proc Natl Acad Sci U S A (1993) 0.84
In vitro and in vivo methods to determine the interactions of osteogenic cells with biomaterials. J Mater Sci Mater Med (2004) 0.81
Effects of JSOG-6 on protection against bone loss in ovariectomized mice through regulation of osteoblast differentiation and osteoclast formation. BMC Complement Altern Med (2014) 0.79
Hypocalcitonemia in Handigodu Disease: a spondylo epi (meta) physeal dysplasia. Int J Clin Exp Med (2010) 0.78
Changes in matrix protein gene expression associated with mineralization in the differentiating chick limb-bud micromass culture system. J Cell Biochem (2011) 0.78
Endogenous bone morphogenetic proteins mediate 1alpha, 25-dihydroxyvitamin D(3)-induced expression of osteoblast differentiation markers in human dermal fibroblasts. J Orthop Res (2009) 0.76
A new method for the preparation of bioactive calcium phosphate films hybridized with 1alpha,25-dihydroxyvitamin D3. J Mater Sci Mater Med (2009) 0.75
A facile in vitro model to study rapid mineralization in bone tissues. Biomed Eng Online (2014) 0.75
Vitamin D Status: Current Opinion on Critical Levels for Plasma Calcium and Bone Mineral Homeostasis. EJIFCC (2011) 0.75
[Pharmaceutical therapy of bone metabolism disorders in chronic kidney disease mineral bone disorder (CKD-MBD) with special respect to antiresorptive substances]. Z Rheumatol (2014) 0.75
Increased osteoblast viability at alkaline pH in vitro provides a new perspective on bone regeneration. Biochem Biophys Rep (2017) 0.75
Progressive development of the rat osteoblast phenotype in vitro: reciprocal relationships in expression of genes associated with osteoblast proliferation and differentiation during formation of the bone extracellular matrix. J Cell Physiol (1990) 4.27
Osteocalcin and matrix Gla protein: vitamin K-dependent proteins in bone. Physiol Rev (1989) 3.87
Direct identification of the calcium-binding amino acid, gamma-carboxyglutamate, in mineralized tissue. Proc Natl Acad Sci U S A (1975) 3.46
Intraembryonic hematopoietic cell migration during vertebrate development. Proc Natl Acad Sci U S A (1995) 3.27
Time sequence of nuclear pore formation in phytohemagglutinin-stimulated lymphocytes and in HeLa cells during the cell cycle. J Cell Biol (1972) 3.03
Relationship of cell growth to the regulation of tissue-specific gene expression during osteoblast differentiation. FASEB J (1990) 2.55
Molecular mechanisms mediating proliferation/differentiation interrelationships during progressive development of the osteoblast phenotype. Endocr Rev (1993) 2.52
Subnuclear targeting of Runx/Cbfa/AML factors is essential for tissue-specific differentiation during embryonic development. Proc Natl Acad Sci U S A (2001) 2.52
The synthesis of acidic chromosomal proteins during the cell cycle of HeLa S-3 cells. I. The accelerated accumulation of acidic residual nuclear protein before the initiation of DNA replication. J Cell Biol (1972) 2.35
Concepts of osteoblast growth and differentiation: basis for modulation of bone cell development and tissue formation. Crit Rev Oral Biol Med (1992) 2.27
Runt homology domain proteins in osteoblast differentiation: AML3/CBFA1 is a major component of a bone-specific complex. J Cell Biochem (1997) 2.27
Groucho/TLE/R-esp proteins associate with the nuclear matrix and repress RUNX (CBF(alpha)/AML/PEBP2(alpha)) dependent activation of tissue-specific gene transcription. J Cell Sci (2000) 2.08
Identification of a nuclear matrix targeting signal in the leukemia and bone-related AML/CBF-alpha transcription factors. Proc Natl Acad Sci U S A (1997) 2.06
Transcriptional control of osteoblast growth and differentiation. Physiol Rev (1996) 2.06
Regulatory roles of Runx2 in metastatic tumor and cancer cell interactions with bone. Cancer Metastasis Rev (2006) 2.04
Purification and properties of Clostridium difficile cytotoxin B. J Biol Chem (1986) 1.97
Nonhistone chromosomal proteins and gene regulation. Science (1974) 1.92
Runx2 association with progression of prostate cancer in patients: mechanisms mediating bone osteolysis and osteoblastic metastatic lesions. Oncogene (2009) 1.87
Transcriptional autoregulation of the bone related CBFA1/RUNX2 gene. J Cell Physiol (2000) 1.76
A specific targeting signal directs Runx2/Cbfa1 to subnuclear domains and contributes to transactivation of the osteocalcin gene. J Cell Sci (2001) 1.74
Multiple Cbfa/AML sites in the rat osteocalcin promoter are required for basal and vitamin D-responsive transcription and contribute to chromatin organization. Mol Cell Biol (1999) 1.72
Osteocalcin: isolation, characterization, and detection. Methods Enzymol (1984) 1.62
Stage-specific expression of Dlx-5 during osteoblast differentiation: involvement in regulation of osteocalcin gene expression. Mol Endocrinol (1997) 1.61
Rapid purification of covalently closed circular DNAs of bacterial plasmids and animal tumor viruses. Anal Biochem (1980) 1.60
Development of the osteoblast phenotype: molecular mechanisms mediating osteoblast growth and differentiation. Iowa Orthop J (1995) 1.60
runt homology domain transcription factors (Runx, Cbfa, and AML) mediate repression of the bone sialoprotein promoter: evidence for promoter context-dependent activity of Cbfa proteins. Mol Cell Biol (2001) 1.59
Activation of a cell-cycle-regulated histone gene by the oncogenic transcription factor IRF-2. Nature (1995) 1.54
Transient upregulation of CBFA1 in response to bone morphogenetic protein-2 and transforming growth factor beta1 in C2C12 myogenic cells coincides with suppression of the myogenic phenotype but is not sufficient for osteoblast differentiation. J Cell Biochem (1999) 1.54
Osteoblast-specific gene expression after transplantation of marrow cells: implications for skeletal gene therapy. Proc Natl Acad Sci U S A (1999) 1.53
Intranuclear targeting of AML/CBFalpha regulatory factors to nuclear matrix-associated transcriptional domains. Proc Natl Acad Sci U S A (1998) 1.52
Cells capable of bone production engraft from whole bone marrow transplants in nonablated mice. J Exp Med (1999) 1.51
Expression of differentiated function by mineralizing cultures of chicken osteoblasts. Dev Biol (1987) 1.51
Factors that promote progressive development of the osteoblast phenotype in cultured fetal rat calvaria cells. J Cell Physiol (1990) 1.50
The nuclear matrix protein NMP-1 is the transcription factor YY1. Proc Natl Acad Sci U S A (1995) 1.49
Osteocalcin gene promoter-binding factors are tissue-specific nuclear matrix components. Proc Natl Acad Sci U S A (1993) 1.46
Regulation of human histone gene expression: transcriptional and posttranscriptional control in the coupling of histone messenger RNA stability with DNA replication. Biochemistry (1987) 1.46
Negative interaction between lithium and electroconvulsive therapy--a case-control study. Br J Psychiatry (1996) 1.42
Multiple H4 histone mRNAs of HeLa cells are encoded in different genes. Nature (1982) 1.41
The temporal and spatial subnuclear organization of skeletal gene regulatory machinery: integrating multiple levels of transcriptional control. Calcif Tissue Int (2003) 1.40
The tissue-specific nuclear matrix protein, NMP-2, is a member of the AML/CBF/PEBP2/runt domain transcription factor family: interactions with the osteocalcin gene promoter. Biochemistry (1995) 1.40
Smad-Runx interactions during chondrocyte maturation. J Bone Joint Surg Am (2001) 1.39
The presence of gamma-carboxyglutamic acid in the proteins associated with ectopic calcification. Biochem Biophys Res Commun (1976) 1.38
Replication-dependent histone gene expression is related to Cajal body (CB) association but does not require sustained CB contact. Mol Biol Cell (2001) 1.38
Tumor cells exhibit deregulation of the cell cycle histone gene promoter factor HiNF-D. Science (1990) 1.37
Differential regulation of the two principal Runx2/Cbfa1 n-terminal isoforms in response to bone morphogenetic protein-2 during development of the osteoblast phenotype. Endocrinology (2001) 1.34
Nuclear matrix association of multiple sequence-specific DNA binding activities related to SP-1, ATF, CCAAT, C/EBP, OCT-1, and AP-1. Biochemistry (1993) 1.33
Osteocalcin gene promoter: unlocking the secrets for regulation of osteoblast growth and differentiation. J Cell Biochem Suppl (1998) 1.32
Angiotensin II-stimulated Na+/H+ exchange in cultured vascular smooth muscle cells. Evidence for protein kinase C-dependent and -independent pathways. J Biol Chem (1987) 1.31
Carboxylated calcium-binding proteins and vitamin K. N Engl J Med (1980) 1.31
Vitamin D-mediated modifications in protein-DNA interactions at two promoter elements of the osteocalcin gene. Proc Natl Acad Sci U S A (1990) 1.30
CDP/cut is the DNA-binding subunit of histone gene transcription factor HiNF-D: a mechanism for gene regulation at the G1/S phase cell cycle transition point independent of transcription factor E2F. Proc Natl Acad Sci U S A (1996) 1.28
Human H4 histone gene transcription requires the proliferation-specific nuclear factor HiNF-D. Auxiliary roles for HiNF-C (Sp1-like) and HiNF-A (high mobility group-like). J Biol Chem (1989) 1.28
Developmental expression and activities of specific fos and jun proteins are functionally related to osteoblast maturation: role of Fra-2 and Jun D during differentiation. Endocrinology (1996) 1.28
The developmental stages of osteoblast growth and differentiation exhibit selective responses of genes to growth factors (TGF beta 1) and hormones (vitamin D and glucocorticoids). J Oral Implantol (1993) 1.27
Changes in the stability of a human H3 histone mRNA during the HeLa cell cycle. Mol Cell Biol (1991) 1.26
Apoptosis during bone-like tissue development in vitro. J Cell Biochem (1998) 1.25
The presence of protein-bound gamma-carboxyglutamic acid in calcium-containing renal calculi. J Clin Invest (1977) 1.24
The t(8;21) chromosomal translocation in acute myelogenous leukemia modifies intranuclear targeting of the AML1/CBFalpha2 transcription factor. Proc Natl Acad Sci U S A (1999) 1.24
Runx2/Cbfa1: a multifunctional regulator of bone formation. Curr Pharm Des (2003) 1.23
Crystal structure of the nuclear matrix targeting signal of the transcription factor acute myelogenous leukemia-1/polyoma enhancer-binding protein 2alphaB/core binding factor alpha2. J Biol Chem (1999) 1.22
An AML-1 consensus sequence binds an osteoblast-specific complex and transcriptionally activates the osteocalcin gene. Proc Natl Acad Sci U S A (1996) 1.21
Sp1 trans-activation of cell cycle regulated promoters is selectively repressed by Sp3. Biochemistry (1995) 1.21
The pattern of mental change and body weight change in the first post-partum week. J Psychosom Res (1980) 1.21
Transcriptional control of the tissue-specific, developmentally regulated osteocalcin gene requires a binding motif for the Msx family of homeodomain proteins. Proc Natl Acad Sci U S A (1994) 1.20
Targeting of the YY1 transcription factor to the nucleolus and the nuclear matrix in situ: the C-terminus is a principal determinant for nuclear trafficking. J Cell Biochem (1998) 1.19
The Role of RUNX2 in Osteosarcoma Oncogenesis. Sarcoma (2010) 1.18